Navigation Links
Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Date:11/10/2008

Paul Richardson, MD to present results from Phase 1/2 Clinical Trial of Perifosine in combination with Bortezomib (+/- dexamethasone) on Tuesday, December 9, 2008 at 8:30am

NEW YORK, Nov. 10 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) has been selected for oral presentation at the upcoming 50th Annual Meeting of the American Society of Hematology (ASH), to be held in San Francisco from December 5-9, 2008.

The study entitled "Phase I/II Results of a Multicenter Trial of Perifosine (KRX-0401) + Bortezomib in Patients with Relapsed or Relapsed / Refractory Multiple Myeloma Who Were Previously Relapsed from or Refractory to Bortezomib," will be presented on Tuesday, December 9th at 8:30 am PST by Paul Richardson, M.D., Clinical Director of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute in Boston, MA.

This abstract became available for viewing earlier today on the American Society of Hematology website (http://www.hematology.org). There were 76 patients enrolled on study at the time of abstract submission, of which 57 were evaluable for response and are reported on within the abstract. An updated analysis will be presented at the conference. As detailed in the abstract, an overall response rate of 40% was seen in evaluable patients. A similar level of activity was seen in the subset of patients who were bortezomib-refractory. In the study, overall response rate is defined to include all MRs, PRs and CRs.

Paul Richardson, MD commented, "The addition of perifosine to bortezomib, with or without dexamethasone, has proved gen
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
2. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
6. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
7. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
8. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
9. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
10. Lippincott Williams & Wilkins Selected as Publisher of the Journal of Neuroscience Nursing
11. Emdeon Selected by the Maryland Hospital Association to Power the Maryland Transaction Data Interchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 The American ... will be on the topics of the DAOM Program as ... DAOM Program Overview Webinar will be hosted by Dr. Carla ... provide the next steps on how to prepare for the ... p.m. March 25, March 27, April 1 and April 3. ...
(Date:3/26/2015)... Doctors Scott Sullivan and Frank DellaCroce, Co-Founders of the ... the St. Charles Surgical Hospital (SCSH) in ... Surgical Oncologist Dr. William Karl Ordoyne has joined their ... surgical oncologist Alan Stolier, M.D., FACS and the team ... Sullivan, M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten ...
(Date:3/26/2015)... PA (PRWEB) March 26, 2015 The ... a new team of nationally renowned scientists to focus ... B, a move that nearly triples its research capacity ... focusing solely on hepatitis B and liver cancer in ... Timothy Block, Jinhong Chang, Ju Tao Guo and Ying-Hsiu ...
(Date:3/26/2015)... 2015 Behavioral Research Group, LLC ... the release of BathroomMap® , a new bathroom ... to public restrooms for travelers, especially those with medical ... does not facilitate a paid, social or crowdsourced model, ... rate local establishments that have clean, available restrooms in ...
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... Lighting the Way, Brightening the Day, on Friday, May ... in Morristown, NJ. , Guests will enjoy an ... Clemente, delightful cuisine, an extensive silent auction and heart-warming ... prestigious awards will be presented to this year’s honorees. ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2
... China Yingxia,International, Inc. (OTC Bulletin Board: CYXI) ... the nutraceutical industry engaged in the,development, manufacture ... and personal care products in the People,s ... has retained CCG Elite to design,and execute ...
... About the Importance of Regular Eye Care, ... the nationwide launch of its "See America" contest, ... preventive eye exams to promote,overall vision health. The ... sight will award the grand prize winner,with the ...
... Clinicogenomic Model Has Highest Prediction Accuracy for Lung ... an emerging,leader in the field of molecular diagnostics ... model for lung cancer diagnosis in the,inaugural edition ... American Association for Cancer Research (AACR), which is ...
... to expand the $200 million surgical ... Group, WALTHAM, Mass., April 14, 2008 According ... 2008 report,the surgical navigation market was worth almost $200 ... five years. This growth will be partly,facilitated by soft ...
... BioElectronics President, CEO, and Chairman Issues Shareholder ... Andrew Whelan,President, CEO and Chairman of BioElectronics, ... FDA-cleared, drug-free anti-inflammatory patch,with an embedded battery ... relieve pain and speed healing, today issued ...
... 14 The rating,agency Standard & Poor,s has raised ... stable". This means that Gerresheimer is now only one,step ... justification for the upgrade, Standard & Poor,s emphasises the,positive ... EBITDA.,Gerresheimer, it says, will be able to sustain this ...
Cached Medicine News:Health News:China Yingxia International, Inc. Retains CCG Elite 2Health News:China Yingxia International, Inc. Retains CCG Elite 3Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 2Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 3Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 4Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 2Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 3Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 2Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 2Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 4Health News:Standard & Poor's Raises Gerresheimer Rating to BB+ 2
(Date:3/26/2015)... ARLINGTON, Va. , March 26, 2015 /PRNewswire/ ... on advancing the use of health technology innovations ... experience, and foster collaborations to improve development and ... work on the structures and processes within delivery ... convening healthcare providers, investors, entrepreneurs, developers and other ...
(Date:3/26/2015)... March 26, 2015 According ... Drug Safety Software Market by Functionality (Adverse Event Reporting, ... (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) ... the Pharmacovigilance and Drug Safety Software Market is ... during 2014-2019, and is expected to reach a ...
(Date:3/26/2015)... , March 26, 2015  Flexpoint Sensor Systems, ... new customers it has received and shipped during the ... a lot of interest in the sensors for gloves ... sensors or have had custom sensors built for them. ... who received custom sensors for medical rehab; a major ...
Breaking Medicine Technology:HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 2HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 3HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2
Padgett Osteotome...
... core product. It is created using the Panoramic200 ... for the screening of eye and non-eye diseases ... examination basis and is non-reimbursable. The optomap provides ... of the patients retina which is viewed on-screen ...
... an ideal gamma camera for ... ability to perform bone and ... perfusion diagnosis and SPECT studies. ... and space efficient solution for ...
Tungsten Carbide wire twister....
Medicine Products: